Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS
Cepheid Xpert Xpress CoV-2/Flu/RSV plus Cepheid Xpert Xpress CoV-2/Flu/RSV plus Cepheid Xpert Xpress CoV-2/Flu/RSV plus
Cepheid Xpert Xpress CoV-2/Flu/RSV plus
Cepheid Xpert Xpress CoV-2/Flu/RSV plus Cepheid Xpert Xpress CoV-2/Flu/RSV plus

Cepheid Xpert Xpress CoV-2/Flu/RSV plus

Product Details:

  • Display Type Instrument dependent
  • Accuracy High (>95%)
  • Usage Type Single use cartridge
  • Function Simultaneous detection and differentiation of respiratory viruses
  • Instruments Type IVD Cartridge for use with GeneXpert systems
  • Features Multiplex detection, sample to answer, minimal hands-on time, rapid results
  • Measurement Range Qualitative (Detected/Not Detected)
  • Click to View more
X

Cepheid Xpert Xpress CoV-2/Flu/RSV plus Price And Quantity

  • GeneXpert and GeneXpert Infinity Systems
  • Approx. 36 minutes
  • System dependent (1-80+ tests/hr depending on GeneXpert platform)
  • Nasopharyngeal swab, nasal swab, or other respiratory specimens
  • CE-IVD, FDA Emergency Use Authorization (EUA)
  • Sample volume per cartridge: ~300 µL
  • SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV)
  • Yes
  • Automated by system software
  • Laboratory professionals, healthcare practitioners

Cepheid Xpert Xpress CoV-2/Flu/RSV plus Product Specifications

  • Nucleic Acid Amplification Test (NAAT) System Cartridge
  • Automated
  • Qualitative detection of SARS-CoV-2, Influenza A, Influenza B, and RSV
  • Cartridge: Approx. 5.7 x 2.2 x 1.0 inches
  • Cartridge: Approx. 60 g
  • Yes (system dependent)
  • Instrument dependent
  • New
  • Transparent with colored labeling
  • Depends on instrument system
  • Compatible with GeneXpert instrument (electricity required)
  • As indicated by manufacturer, typically 12-18 months
  • Qualitative (Detected/Not Detected)
  • RT-PCR (Real-Time Polymerase Chain Reaction)
  • Yes
  • Store at 2-28C, do not freeze
  • Multiplex detection, sample to answer, minimal hands-on time, rapid results
  • Depends on instrument system
  • IVD Cartridge for use with GeneXpert systems
  • No
  • Simultaneous detection and differentiation of respiratory viruses
  • Single use cartridge
  • Plastic, proprietary cartridge materials
  • High (>95%)
  • GeneXpert and GeneXpert Infinity Systems
  • Approx. 36 minutes
  • System dependent (1-80+ tests/hr depending on GeneXpert platform)
  • Nasopharyngeal swab, nasal swab, or other respiratory specimens
  • CE-IVD, FDA Emergency Use Authorization (EUA)
  • Sample volume per cartridge: ~300 µL
  • SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV)
  • Yes
  • Automated by system software
  • Laboratory professionals, healthcare practitioners

Product Description

Brand                           Cepheid

Product Type               PCR Kit

Pack Size                     10T

CAT No                         XP3COV2/FLU/RSV-10

Application                  Molecular Biology

The Xpert Xpress CoV-2/Flu/RSV plus test is a multiplexed real-time PCR test intended for the simultaneous in vitro qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A, influenza B, and/or RSV in nasopharyngeal swab or anterior nasal swab specimens collected from individuals with signs and/or symptoms of respiratory viral infection.
The Xpert Xpress CoV-2/Flu/RSV plus test:

  • Provides fast and accurate results in as early as 25 minutes# for SARS-CoV-2.
  • Utilizes a multi-gene target approach for the detection of SARS-CoV-2 and influenza providing target redundancy to mitigate the potential impact of genetic shift and drift on strain detection.
  • Detects SARS-CoV-2, influenza A, influenza B, and/or RSV simultaneously.



Comprehensive, Multiplex Detection in a Single Cartridge

The Cepheid Xpert Xpress CoV-2/Flu/RSV plus allows simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A, Influenza B, and RSV, all from a single patient specimen. This streamlines decision-making for clinicians and supports efficient patient management, particularly in respiratory infection seasons.


Fast Turnaround and Easy Usage

With a runtime of approximately 36 minutes from sample to result, the assay offers nearly immediate diagnostic feedback. The automated process, minimal sample preparation, and clear system-guided result output significantly reduce the manual burden on laboratory staff.


Flexible and Scalable Testing Workflows

Compatible with GeneXpert platforms, test throughput ranges from single cartridges to 80+ tests per hour, enabling high-volume laboratories and smaller centers to scale testing based on current needs. Portable cartridge design allows for deployment in varying clinical environments.

FAQ's of Cepheid Xpert Xpress CoV-2/Flu/RSV plus:


Q: How does the Cepheid Xpert Xpress CoV-2/Flu/RSV plus test operate?

A: The test leverages real-time RT-PCR within a single-use cartridge, requiring only around 300 L of sample. Laboratories place the cartridge into a compatible GeneXpert system, which automates the entire process from nucleic acid extraction to result reporting.

Q: What types of samples are required for this assay?

A: The test accepts nasopharyngeal swabs, nasal swabs, or other respiratory specimens collected according to standard procedures recommended for respiratory virus testing.

Q: When should healthcare practitioners use this test?

A: This assay is intended for use when rapid and simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and RSV is clinically indicated, such as during symptomatic presentation, outbreaks, or respiratory infection seasons.

Q: Where can the Cepheid Xpert Xpress CoV-2/Flu/RSV plus be implemented?

A: The cartridge is designed for laboratory and clinical environments equipped with a GeneXpert or GeneXpert Infinity system, including hospital labs, reference laboratories, and diagnostic centers.

Q: What is the process for obtaining results from the test?

A: Collected samples are loaded into the cartridge, which is then inserted into the GeneXpert instrument. The fully automated run delivers qualitative results (Detected/Not Detected) for each virus in about 36 minutes, displayed via the system's software interface.

Q: What are the main benefits of using this assay?

A: Key advantages include rapid turnaround, high accuracy (>95%), multiplexing capability, minimal manual handling, and automated result interpretation, supporting both clinical effectiveness and workflow efficiency.

Q: How should the cartridges be stored and handled before use?

A: Store cartridges at 2-28C and avoid freezing. They should remain in their packaging until use, and always follow the manufacturer's shelf life and storage guidelines for optimal performance.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical Reagents' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.